caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1679695928

Mila GorskyM.D.

Hematology-OncologyBasking Ridge, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
218
Unique beneficiaries
—
Total services
393
Distinct HCPCS
4
Medicare payment
$30K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 301 Hematology-Oncology providers in NJ — bottom quintile (cohort median 3,501).
REFERRAL NETWORK

Where Mila Gorsky's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Karen Dougherty
Nurse Practitioner · Basking Ridge, NJ
93275
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
39131
Asma Latif
Hematology-Oncology · Attleboro, MA
27224
Deborah Capko
Surgical Oncology · Basking Ridge, NJ
27126
Stefanie Jacobs
Diagnostic Radiology · Englewood, NJ
2572
Sree Bhavani Chalasani
Hematology-Oncology · Basking Ridge, NJ
18102
HAMILTON, AUDREY16124
Jean Torrisi
Diagnostic Radiology · New York, NY
1553
Mario Leitao
Gynecological Oncology · New York, NY
1359
Genomic Health, Inc.
Clinical Laboratory · Redwood City, CA
1121
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
449
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
10
Brand share
21.2%
Top prescribed drugs
Anastrozole234 claims
Palbociclib59 claims
Tamoxifen Citrate56 claims
Abemaciclib25 claims
Exemestane15 claims
QUALITY · MIPS · 2024
Final MIPS score
81.6
Quality
72.3
Cost
76.6
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.28%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.